This brand name is authorized in Ecuador, Estonia, Finland, France, Croatia, Malta, Poland, Romania, United Kingdom
The drug OCTAPLASLG contains one active pharmaceutical ingredient (API):
|
1
UNII 6D53G0FD0Z - PLASMA PROTEIN FRACTION (HUMAN)
|
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| OCTAPLASLG Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B05AA | Blood substitutes and plasma protein fractions | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 223-MBE-1221 |
| Country: EE | Ravimiamet | Identifier(s): 1593187, 1674592, 1674604, 1685235, 1802652, 1802663, 1802674, 1802685 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 004263, 004280, 004295, 004297 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60074795 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 336602, 336605, 336610, 336613 |
| Country: MT | Medicines Authority | Identifier(s): MA1219/00901, MA1219/00902 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100340046 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W65357001, W65357002, W65357003, W65357004 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
